US Stock MarketDetailed Quotes
HUMA Humacyte
- 4.100
- +0.020+0.49%
Close Dec 13 16:00 ET
- 4.130
- +0.030+0.73%
Post 20:01 ET
527.54MMarket Cap-3.06P/E (TTM)
4.220High4.013Low1.64MVolume4.120Open4.080Pre Close6.74MTurnover1.72%Turnover RatioLossP/E (Static)128.67MShares9.97052wk High-8.28P/B391.99MFloat Cap2.48052wk Low--Dividend TTM95.61MShs Float17.450Historical High--Div YieldTTM5.08%Amplitude1.960Historical Low4.108Avg Price1Lot Size
Humacyte Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -76.11%-22.91M | 5.80%-21.29M | -46.70%-27.35M | -3.06%-73.31M | -0.50%-19.05M | 22.60%-13.01M | -36.42%-22.6M | 0.83%-18.64M | 12.39%-71.13M | 11.60%-18.96M |
| Net income from continuing operations | -50.81%-39.2M | -149.55%-56.66M | 13.72%-31.9M | -825.83%-110.78M | -574.89%-25.11M | -2.82%-26M | -161.59%-22.71M | -86.41%-36.97M | 54.81%-11.97M | -108.74%-3.72M |
| Operating gains losses | -875.56%-1.05M | -84.40%388K | -242.86%-60K | 756.69%2.7M | 120.47%35K | 101.49%135K | 1,167.38%2.49M | 156.76%42K | 87.69%-411K | -194.83%-171K |
| Depreciation and amortization | -0.98%1.81M | -10.29%1.78M | -13.60%1.79M | -5.98%7.72M | -13.29%1.83M | -10.07%1.83M | -1.88%1.98M | 1.62%2.07M | -0.38%8.21M | 3.32%2.11M |
| Other non cash items | 380.18%10.56M | 1,105.44%27.71M | -58.63%6.02M | 118.41%13.65M | 97.90%-353K | 55.59%2.2M | 95.07%-2.76M | 607.60%14.56M | -35.50%-74.18M | 74.27%-16.77M |
| Change In working capital | -51.58%3.41M | 217.56%4.06M | -2,830.82%-4.66M | 538.58%6.57M | 250.53%3.13M | 102.32%7.05M | -350.07%-3.45M | -140.66%-159K | 284.74%1.03M | -33.85%-2.08M |
| -Change in receivables | --0 | --0 | --0 | -78.62%31K | --0 | --0 | --0 | 154.39%31K | 330.16%145K | --0 |
| -Change in prepaid assets | -96.51%113K | 96.67%-126K | 240.83%409K | -128.45%-388K | -93.66%35K | 2,175.00%3.24M | -2,689.04%-3.78M | -85.40%120K | 162.74%1.36M | 420.93%552K |
| -Change in payables and accrued expense | -13.40%3.31M | 1,134.41%4.2M | -1,596.64%-5.06M | 2,763.36%6.98M | 227.00%3.11M | 60.60%3.83M | 104.82%340K | 17.91%-298K | -114.25%-262K | -85.45%-2.45M |
| -Change in other current liabilities | 0.00%-13K | -8.33%-13K | -8.33%-13K | -11.11%-50K | -18.18%-13K | -8.33%-13K | -9.09%-12K | -9.09%-12K | -7.14%-45K | -10.00%-11K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -49.14%-173K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -76.11%-22.91M | 5.80%-21.29M | -46.70%-27.35M | -3.06%-73.31M | -0.50%-19.05M | 22.60%-13.01M | -36.42%-22.6M | 0.83%-18.64M | 12.39%-71.13M | 11.60%-18.96M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -89.45%-934K | -111.34%-184K | 66.06%-391K | -103.57%-173K | -102.88%-150K | -133.65%-493K | 1,310.45%1.62M | -5,136.36%-1.15M | 158.94%4.85M | 164.79%5.21M |
| Net PPE purchase and sale | -89.45%-934K | 62.06%-184K | 66.06%-391K | -117.56%-2.28M | 77.97%-150K | -133.65%-493K | -261.94%-485K | -5,136.36%-1.15M | -376.36%-1.05M | -1,413.33%-681K |
| Net investment purchase and sale | --0 | ---- | ---- | -64.25%2.11M | --0 | --0 | ---- | ---- | 173.66%5.89M | 173.66%5.89M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -89.45%-934K | -111.34%-184K | 66.06%-391K | -103.57%-173K | -102.88%-150K | -133.65%-493K | 1,310.45%1.62M | -5,136.36%-1.15M | 158.94%4.85M | 164.79%5.21M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 211.13%849K | -107.76%-467K | 15,453.30%62.8M | 411.69%4.51M | -58.02%-335K | -164.36%-764K | 1,342.77%6.02M | 11.28%-409K | -100.54%-1.45M | -103.24%-212K |
| Net issuance payments of debt | -14.21%-659K | 98.01%-644K | -14.20%-603K | -1,619.64%-34.07M | -13.51%-588K | -14.03%-577K | -6,440.00%-32.37M | -14.29%-528K | -107.09%-1.98M | -105.43%-518K |
| Net common stock issuance | --1.01M | --0 | --43.4M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 400.00%495K | 728.42%787K | -98.32%2K | 5.79%566K | -17.32%253K | -54.38%99K | 763.64%95K | 11,800.00%119K | -10.54%535K | 15,200.00%306K |
| Net other financing activities | --0 | ---610K | --20M | --38.01M | --0 | ---286K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 211.13%849K | -107.76%-467K | 15,453.30%62.8M | 411.69%4.51M | -58.02%-335K | -164.36%-764K | 1,342.77%6.02M | 11.28%-409K | -100.54%-1.45M | -103.24%-212K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.05%93.92M | -10.58%115.86M | -46.05%80.8M | -31.14%149.77M | -38.72%100.34M | -36.70%114.6M | -34.63%129.57M | -31.14%149.77M | 444.72%217.5M | -31.91%163.73M |
| Current changes in cash | -61.19%-22.99M | -46.61%-21.94M | 273.53%35.06M | -1.83%-68.97M | -39.97%-19.54M | 17.57%-14.26M | 12.92%-14.97M | -4.78%-20.2M | -138.14%-67.73M | 39.17%-13.96M |
| End cash Position | -29.32%70.92M | -18.05%93.92M | -10.58%115.86M | -46.05%80.8M | -46.05%80.8M | -38.72%100.34M | -36.70%114.6M | -34.63%129.57M | -31.14%149.77M | -31.14%149.77M |
| Free cash flow | -76.60%-23.84M | 6.99%-21.48M | -40.14%-27.74M | -4.72%-75.59M | 2.22%-19.2M | 20.66%-13.5M | -38.23%-23.09M | -5.18%-19.79M | 11.34%-72.18M | 8.62%-19.64M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data